Will Bristol-Myers Share Merck’s Woe?
June 13, 2017 at 11:50 AM EDT
Merck's cancer drug Keytruda hit a bit of speed bump today. One analyst asked if Bristol-Myers Squibb's rival drug faces a similar problem.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|